申万菱信中证申万医药生物指数(LOF)C(015176)资产负债表
| |
2025-06-30 |
2024-12-31 |
2024-06-30 |
2023-12-31 |
| 资产 |
| 银行存款 |
- |
- |
- |
- |
| 结算备付金 |
- |
6,897.80 |
18,519.86 |
3,383.64 |
| 存出保证金 |
7,743.83 |
8,557.88 |
10,982.40 |
7,369.35 |
| 交易性金融资产 |
222,915,600.99 |
210,793,204.01 |
206,300,063.09 |
250,090,240.77 |
| 其中：股票投资 |
222,915,600.99 |
210,793,204.01 |
206,300,063.09 |
250,090,240.77 |
| 债券投资 |
- |
- |
- |
- |
| 资产支持证券投资 |
- |
- |
- |
- |
| 衍生金融资产 |
- |
- |
- |
- |
| 买入返售金融资产 |
- |
- |
- |
- |
| 应收证券清算款 |
12,299.21 |
121,529.05 |
- |
- |
| 应收利息 |
- |
- |
- |
- |
| 应收股利 |
- |
- |
- |
- |
| 应收申购款 |
166,993.50 |
252,196.17 |
247,264.26 |
273,583.18 |
| 其他资产 |
- |
- |
- |
- |
| 资产总计 |
238,412,098.04 |
226,428,456.27 |
221,916,611.03 |
267,882,431.57 |
| 负 债 |
| 短期借款 |
- |
- |
- |
- |
| 交易性金融负债 |
- |
- |
- |
- |
| 衍生金融负债 |
- |
- |
- |
- |
| 卖出回购金融资产款 |
- |
- |
- |
- |
| 应付证券清算款 |
- |
- |
377,164.20 |
- |
| 应付赎回款 |
758,399.06 |
651,146.51 |
235,132.91 |
562,656.91 |
| 应付管理人报酬 |
193,039.80 |
200,402.84 |
189,712.56 |
227,207.60 |
| 应付托管费 |
38,607.97 |
40,080.55 |
37,942.50 |
45,441.49 |
| 应付销售服务费 |
6,951.53 |
7,357.30 |
7,080.66 |
9,184.54 |
| 应付交易费用 |
- |
- |
- |
- |
| 应交税费 |
- |
- |
- |
- |
| 应付利息 |
- |
- |
- |
- |
| 应付利润 |
- |
- |
- |
- |
| 其他负债 |
94,310.90 |
193,558.09 |
145,970.77 |
232,322.87 |
| 负债合计 |
1,091,309.26 |
1,092,545.29 |
993,003.60 |
1,076,813.41 |
| 所有者权益 |
| 实收基金 |
242,782,767.54 |
242,608,493.72 |
256,414,847.49 |
254,249,063.63 |
| 未分配利润 |
-5,461,978.76 |
-17,272,582.74 |
-35,491,240.06 |
12,556,554.53 |
| 所有者权益合计 |
237,320,788.78 |
225,335,910.98 |
220,923,607.43 |
266,805,618.16 |
| 负债及所有者权益总计 |
238,412,098.04 |
226,428,456.27 |
221,916,611.03 |
267,882,431.57 |
微信公众号
证券之星APP
基本资料
